期刊文献+

急性非ST段抬高型心肌梗死患者术前应用替罗非班对冠状动脉血流及心肌灌注的影响 被引量:4

下载PDF
导出
摘要 选择2014年2月~2016年3月我院收治的行经皮冠状动脉介入治疗(PCI)的急性非ST段抬高型心梗的患者96例,按随机数字原则分为观察组和对照组各48例,对照组给予术前常规治疗,观察组在此基础上给予替罗非班,比较两组TIMI血流分级、心肌灌注TMPG及不良心脏事件发生率等情况。结果观察组术后TIMI血流分级情况整体优于对照组,其中次重要及轻微例数与对照组相比差异具有统计学意义(P<0.05)。急性非ST段抬高型心肌梗死患者术前应用替罗非班可显著改善冠脉血流,提高梗死心肌的灌注水平,且安全性较高,值得临床推广应用。
机构地区 梅州市人民医院
出处 《现代诊断与治疗》 CAS 2017年第16期3055-3056,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献8

二级参考文献80

  • 1陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 2Desch S, Wihrle J, Hambrecht R, et al. Intracoronary versus intra- venous abciximab bolus in patients with ST-segment elevation myo- cardial infaretionl -year results of the randomized AIDA STEMI tri- al[ ] ]. J Am Coll Cardio1,2013,62 ( 13 ) :1214-1215.
  • 3Mohr F W,Morice M C,Kappetein A P,et al. Coronary artery by- pass graft surgery versus percutaneous coronary intervention in pa-tients with three-vessel disease and left main coronary disease:5- year follow-up of the randomised, clinical SYNTAX trial [ J ]. Lan- cet ,2013,381 ( 9867 ) :629-638.
  • 4Berger P B,Janzen M C, Manoukian S V. CRT-33 peri-procedural CK-MB levels in percutaneous coronary intervention with high-dose bolus tirofiban vs. abciximab plus either unfractionated heparin or bivalirudin : an analysis from TENACITY [ J 7- JACC Cardiasc ln- terv,2013,6(2/S) :S11.
  • 5Jia Z, Guo M,Zhang Y Q,et al. Short-term effect of upstream ad- ministration in comparison to deferred injection of tirofiban on pa- tients with acute ST-segment elevation myocardial infarction under- going primary percutaneous coronary intervention[ J]. J Inter Card- iovasc,2013,26 (4) :332-339.
  • 6Niccoli G, Rigattieri S, De Vita M R,et al. Open-label, random- ized, placebo-controlled evaluation of intracoronary adenosine or ni- troprusside afterthrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascularobstmction in acute myocardial infarction:the REOPEN-AMI study (intracoro- nary nitroprusside versus adenosine in acute myocardial infarction) [J]. JACC Cardiovasc lnterv ,2013 ,6( 6 ) :580-589.
  • 7Souza C F, Mehran R, Kirtane A J, et al. Safety and efficacy of bivalirudin monotherapy in patients with non-ST segment elevation myocardial infarction undergoing PCI: results from the ACUITY study[ J]. J Am Coll Cardiol,2013,62( 18/51 ) :B85-B86.
  • 8Sanbom T A, Mehran R, Genereux P, et al. Reduced bleeding complications and increased event-free survival with femoral vas- cular closure device use and bivalirudin in STEMI patients under- going primary angioplasty in the HORIZONS-AMI trial[ J]. J Am Coll Cardiol,2013,62( 18/S1 ) :B95.
  • 9Chorzempa A, Tamis J, Simon C, et al. Safety and feasibility of in- tra-arterial bivalimdin bolus adnlinistration during primary angio- plasty [ J ]. Coron Artery Dis,2013,24 ( 5 ) :419-421.
  • 10Sabbah H N, Gupta R C, Kohli S, et al. Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure[ J]. Circ Heart Fail,2013,6(3 ) :563-571.

共引文献180

同被引文献44

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部